Orum Therapeutics
Orum Therapeutics is seeking an experienced Chief Financial Officer to lead its global finance and accounting organization, overseeing financial reporting, treasury, risk management, tax, and stock plan administration while partnering with executive leadership. The role also provides operational leadership across Investor Relations, Human Resources, and Legal functions, ensuring alignment of financial, communication, and organizational priorities.
Headquarters
Lexington, Massachusetts, United States
Company Size
11-50 employees
Founded
2016
Orum Therapeutics is a biotechnology company developing cell‑specific, targeted protein degraders that combine the selectivity of antibody targeting with the mechanism of targeted protein degradation. Their platform aims to selectively eliminate disease‑relevant proteins in defined cell types, expanding the druggable proteome while improving therapeutic precision and safety. Orum advances proprietary degrader therapeutics and works with partners to translate its technology into new treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Orum Therapeutics.
Orum Therapeutics didn’t post a salary, so this is our estimate from similar listings.
10% below the average for this role